Market Highlights: Over the past few years blockbuster to be born supposed to develop aggressive marketing with rising sales volumes in order to secure monopolistic rents offered by patents rapidly. Blockbuster drugs are defined as the drugs that generate at least USD1 billion in revenue a year for the pharmaceutical companies that produce them Blockbuster drugs are used to treat various ac medical problems. For instance, the medications used to treat diabetes, cholesterol, high blood pressure, and cancer. Part of the success of these drugs stems from the fact that they're needed over a long period of time, and that they play a key role in helping doctors manage their patients' conditions. For this reason, the pharma companies are aiming to develop a diverse and successful range of products instead of depending on one or two blockbuster drugs to keep themselves profitable is booming the demand for blockbuster drugs in the market The market study is being classified by Type (Generic Drug and Brand Name Drug), by Application (Oncology, Immunology, Autoimmune Diseases, Cardiovascular Diseases and Other) and major geographies with country level break-up that includes South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Key Players: The prominent players in the Blockbuster Drugs are Roche (Switzerland), Bristol-Myers Squibb(United States), Pfizer(United States), Eli Lilly and Company(United States), Merck & Co. (United States), Johnson & Johnson (United States), AstraZeneca (United Kingdom), Celgene (United States), Novartis (Switzerland) and Amgen (United States).
The Route of Administration, such as Oral, is boosting the Blockbuster Drugs market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.
The Distribution Channel, such as Online, is boosting the Blockbuster Drugs market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.
Key Questions Answered in the Report What will the Blockbuster Drugs Market size and the growth rate be in Future? What are the key factors driving the Blockbuster Drugs Market? What are the key market trends and macro-economic impacting the growth of the Blockbuster Drugs Market? What are the challenges to market growth? Who are the key vendors in the Blockbuster Drugs Market? What are the market opportunities and threats faced by the vendors in the Blockbuster Drugs Market? Trending factors influencing the market shares of the Players. What are the key outcomes of the five forces analysis of the Blockbuster Drugs Market?
Research Methodology: The top-down and bottom-up approaches are used to estimate and validate the size of the Global Blockbuster Drugs market. In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Blockbuster Drugs market. In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc. Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Blockbuster Drugs Manufacturer, Government Regulatory and Research Organizations and End-Use Industry. This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth etc. Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.